Share this post on:

2-TES-Cabazitaxel

2’-TES-Cabazitaxel is an intermediate in the synthesis of the anti-cancer compound, cabazitazel.

References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/18832478

Cas No.

1380584-07-5

Purity

≥95%

Formula

C45H56NO13

Formula Wt.

818.94

Synonym

1-hydroxy-7β,10β-di-methoxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-trethylsilyloxy-3-phenylpropanoate}; 1-hydroxy-7β,10β-dimethoxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-triethylsilyloxy-3-phenylpropanoate}; 1-hydroxy-7β,10β-di-methoxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-trethylsilyloxy-3-phenylpropanoate}; TES-cabazitaxel;


product targets : LIM Kinase (LIMK) inhibitors
PF-04449913

Share this post on:

Author: Ubiquitin Ligase- ubiquitin-ligase